Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VNN2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | HBP1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | KCNRG | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | CD180 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | UBAC1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
mRNA | TTN | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | SMC5 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | ADAMTS14 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
mRNA | DBR1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |